Mitochondrial dysfunction in chronic ischemia and peripheral vascular disease

Mitochondrion

Volumn 4, Issue 5-6 SPEC. ISS., 2004, Pages 629-640

  Kemp, Graham J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Magnetic resonance spectroscopy; Metabolism; Mitochondria; Muscle; Near infrared spectroscopy; Peripheral vascular disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; MUSCLE ENZYME; OXYGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL HYPOXIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HUMAN; IN VIVO STUDY; ISCHEMIA; MUSCLE MITOCHONDRION; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATION; OXYGEN CONCENTRATION; OXYGEN SUPPLY; OXYGEN TENSION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL;

EID: 10644282111     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2004.07.017     Document Type: Article

References (42)

1. K.A. Anquist M. Sjostrom Intermittent claudication and muscle fibre fine structure: Morphometric data on mitochondrial volumes Ultrastruct. Pathol. 1 1980 461-470
2. T.A. Bauer J.G. Regensteiner E.P. Brass W.R. Hiatt Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease J. Appl. Physiol. 87 1999 809-816
3. H.K. Bhat W.R. Hiatt C.L. Hoppel E.P. Brass Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease Circulation 99 1999 807-812
4. E.P. Brass W.R. Hiatt Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease Vasc. Med. 5 2000 55-59
5. E.P. Brass H. Wang W.R. Hiatt Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease Vasc. Med. 5 2000 225-230
6. E.P. Brass W.R. Hiatt A.W. Gardner C.L. Hoppel Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease Am. J. Physiol. 280 2001 H603-H609
7. A.C. Bylund-Fellenius P.M. Walker A. Elander S. Holm J. Holm T. Scherstén Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise Biochem. J. 200 1981 247-255
8. C.A. Clyne H. Mears R.O. Weller T.F. O'Donnell Calf muscle adaptation to peripheral vascular disease Cardiovasc. Res. 19 1985 507-512
9. A. Egun V. Farooq F. Torella R. Cowley M.S. Thorniley C.N. McCollum The severity of muscle ischemia during intermittent claudication J. Vasc. Surg. 36 2002 89-93
10. A. Elander M. Sjöström F. Lundgren T. Scherstén A.C. Bylund-Fellenius Biochemical and morphometric properties of mitochondrial populations in human muscle fibres Clin. Sci. 69 1985 153-164
11. J. Hammarsten A.C. Bylund-Fellenius J. Holm T. Scherstén M. Krotkiewski Capillary supply and muscle fibre types in patients with intermittent claudication: Relationships between morphology and metabolism Eur. J. Clin. Invest. 10 1980 301-305
12. 2 availability J. Appl. Physiol. 86 1999 2013-2018
13. B. Hedberg K.A. Angquist K. Henriksson-Larsen M. Sjostrom Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency Eur. J. Vasc. Surg. 3 1989 315-322
14. W.R. Hiatt D. Nawaz E.P. Brass Carnitine metabolism during exercise in patients with peripheral vascular disease J. Appl. Physiol. 62 1987 2383-2387
15. W.R. Hiatt E.E. Wolfel J.G. Regensteiner E.P. Brass Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease J. Appl. Physiol. 73 1992 346-353
16. X.Y. Hou S. Green C.D. Askew G. Barker A. Green P.J. Walker Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease Clin. Physiol. Funct. Imaging 22 2002 226-232
17. E. Jansson J. Johansson C. Sylven L. Kaijser Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease Clin. Physiol. 8 1988 17-29
18. U. Keller R. Oberhansli P. Huber L.K. Widmer W.P. Aue R.I. Hassink S. Muller J. Seelig Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs Eur. J. Clin. Invest. 15 1985 382-388
19. 31P magnetic resonance spectroscopy Clin. Sci. 89 1995 581-590
20. G.J. Kemp D.N. Manners M.E. Bastin J.F. Clark G.K. Radda A theoretical model of the mitochondrion/creatine kinase/myofibril system in muscle Mol. Cell. Biochem. 184 1998 249-289
21. 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo J. Vasc. Surg. 34 2001 1103-1110
22. 31P magnetic resonance spectroscopy J. Physiol. 535 2001 901-928
23. G.J. Kemp N. Roberts W.E. Bimson A. Bakran S.P. Frostick Muscle oxygenation and ATP turnover when blood flow is impaired by vascular disease Spectroscopy 16 2002 317-334
24. T. Komiyama H. Shigematsu H. Yasuhara T. Muto An objective assessment of intermittent claudication by near infrared spectroscopy Eur. J. Vasc. Surg. 8 1994 294-296
25. H.M. Kooijman M.T. Hopman W.N. Colier J.A. van der Vliet B. Oeseburg Near infrared spectroscopy for noninvasive assessment of claudication J. Surg. Res. 72 1997 1-7
26. F. Lundgren A.G. Dahllof T. Schersten A.C. Bylund-Fellenius Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance Clin. Sci. 77 1989 485-493
27. K.K. McCully C. Halber J.D. Posner Exercise-induced changes in oxygen saturation in the calf muscles of elderly subjects with peripheral vascular disease J. Gerontol. 49 1994 B128-B134
28. M.R. McGuigan R. Bronks R.U. Newton M.J. Sharman J.C. Graham D.V. Cody W.J. Kraemer Muscle fiber characteristics in patients with peripheral arterial disease Med. Sci. Sports Exerc. 33 2001 2016-2021
29. B. Pernow B. Saltin J. Wahren R. Cronestrand S. Ekestroöm Leg blood flow and muscle metabolism in occlusive arterial disease of the leg before and after reconstructive surgery Clin. Sci. Mol. Med. 49 1975 265-275
30. I.I. Pipinos A.D. Shepard P.V. Anagnostopoulos A. Katsamouris M.D. Boska Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle J. Vasc. Surg. 31 2000 944-952
31. I.I. Pipinos M.D. Boska A.D. Shepard P.V. Anagnostopoulos A. Katsamouris Pentoxifylline reverses oxidative mitochondrial defect in claudicating skeletal muscle J. Surg. Res. 102 2002 126-132
32. I.I. Pipinos V.G. Sharov A.D. Shepard P.V. Anagnostopoulos A. Katsamouris A. Todor K.A. Filis H.N. Sabbah Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease J. Vasc. Surg. 38 2003 827-832
33. J.G. Regensteiner E.E. Wolfel E.P. Brass M.R. Carry S.P. Ringel M.E. Hargarten E.R. Stamm W.R. Hiatt Chronic changes in skeletal muscle histology and function in peripheral arterial disease Circulation 87 1993 413-421
34. 2max in the exercise-trained human quadriceps J. Appl. Physiol. 86 1999 1048-1053
35. 2 consumption in trained human skeletal muscle J. Appl. Physiol. 87 1999 325-331
36. 2 in peripheral arterial occlusive disease patients J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 55 2000 B302-B306
37. K. Schunk B. Romaneehsen P. Mildenberger W. Kersjes S. Schadmand-Fischer M. Thelen Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: Correlation with clinical and angiographic findings and comparison to healthy volunteers Invest. Radiol. 32 1997 651-659
38. K. Schunk B. Romaneehsen O. Rieker C. Düber W. Kersjes S. Schadmand-Fischer W. Schmiedt M. Thelen Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease: Effects of vascular therapy on spectroscopic results Invest. Radiol. 33 1998 329-335
39. J. Steinacker A. Opitz-Gress S. Baur W. Lormes K. Bolkart L. Sunder-Plassmann F. Liewald M. Lehman L. Yuefei Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease J. Vasc. Surg. 31 2000 443-449
40. 2 in human skeletal muscle Am. J. Physiol. 276 1999 R1682-R1690
41. H. Wang W.R. Hiatt T.J. Barstow E.P. Brass Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: Alterations with disease Eur. J. Appl. Physiol. 80 1999 22-27
42. 31 P nuclear magnetic resonance spectroscopy: Noninvasive biochemical analysis of the ischemic extremity J. Vasc. Surg. 3 1986 411-420